WebA single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)夽 Haruyasu Murakami a,∗ , Nobuyuki Yamamoto a,b , Taro Shibata c , Koji Takeda d , Yukito Ichinose e , Yuichiro Ohe f , Noboru Yamamoto g , Yuichiro Takeda h , Shinzoh Kudoh i , Shinji Atagi j , Miyako … WebA single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901) (PDF) A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901) Shinzoh Kudoh, Yukito Ichinose, …
Short-term surgical outcomes from a randomized controlled
WebAbstract Objectives We conducted an open-label, multicenter, single-arm study to confirm the efficacy and safety of amrubicin (AMR), a topoisomerase II inhibitor, for treating … Web1 set 2012 · Material and methods. Patients with SCLC that is refractory or relapsed within 90 days of completing previous treatment received amrubicin at a dose of 40 mg/m 2 for … dr sheila horsley crowley tx
A single-arm confirmatory study of amrubicin therapy in patients …
WebAnalyzes and identifies plan supportability. Identifies limiting factors, shortfalls, and alternate support methods to enhance supportability of transiting and beddown forces. Performs … WebA single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901) (PDF) A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901) Shinzoh Kudoh, Yukito Ichinose, … WebOBJECTIVES: We conducted an open-label, multicenter, single-arm study to confirm the efficacy and safety of amrubicin (AMR), a topoisomerase II inhibitor, for treating refractory small-cell lung cancer (SCLC). PATIENTS AND METHODS: Patients with chemotherapy-refractory SCLC received 40 mg/m(2) AMR for 3 consecutive days, every 21 days. The … colored maternity skinny jeans